Approval · Notice of Compliance 4016 · 1997
FASTIN: Notice of Compliance 4016
Issued June 11, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4016
- Date
- June 11, 1997
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph revision: restriction in indication and new warning
- Therapeutic class
- Anorexiant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FASTIN | Not yet assigned | — |
Medicinal ingredients
- PHENTERMINE HCL 30 MG per CAP